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Abstract Of all patients with Noonan syndrome, 50-90% 
have one or more congenital heart defects. The most 
frequent occurring are pulmonary stenosis (PS) and 
hypertrophic cardiomyopathy. The electrocardiogram 
(ECG) of a patient with Noonan syndrome often shows a 
characteristic pattern, with a left axis deviation, abnormal 
R/S ratio over the left precordium, and an abnormal Q 
wave. The objective of this study was to determine if these 
ECG characteristics are an independent feature of the 
Noonan syndrome or if they are related to the congenital 
heart defect. A cohort study was performed with 118 
patients from two university hospitals in the United States 
and in The Netherlands. All patients were diagnosed with
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definite Noonan syndrome and had had an ECG and 
echocardiography. Sixty-nine patients (58%) had character­
istic abnormalities of the ECG. In the patient group without 
a cardiac defect (n =21), ten patients had a characteristic 
ECG abnormality. There was no statistical relationship 
between the presence of a characteristic ECG abnormality 
and the presence of a cardiac defect (p=0.33). Patients with 
hypertrophic cardiomyopathy had more ECG abnormalities 
in total (p=0.05), without correlation with a specific ECG 
abnormality. We conclude that the ECG features in patients 
with Noonan syndrome are characteristic for the syndrome 
and are not related to a specific cardiac defect. An ECG is 
very useful in the diagnosis of Noonan syndrome; every 
child with a Noonan phenotype should have an ECG and 
echocardiogram for evaluation.
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Abbreviations
PS Pulmonary artery stenosis 
HCM Hypertrophic cardiomyopathy 
ECG Electrocardiogram
Introduction
Noonan syndrome is a relatively common multiple con­
genital anomaly syndrome, the incidence being estimated 
by Nora et al. [19] between 1 per 1,000-2,500 live births. 
Mendez and Opitz [13] consider the frequency to be even 
higher, with 1 per 1,000 severely affected cases and 1 per 
100 with mild expression. The syndrome was first 
described as a distinct syndrome in 1963 by Noonan and
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Ehmke [15] who reported 9 patients with Turner-like 
abnormalities but without the chromosomal pattern of 
Turner syndrome. NS may occur on a sporadic basis or in 
a pattern consistent with autosomal dominant inheritance. 
In 1994 a gene was localized at the long arm of 
chromosome 12 [9], and in 2001 the gene was identified 
as the PTPN11 gene [27]. About 50% of Noonan syndrome 
cases have PTPN11 mutations [25, 27]. PTPN11 encodes 
the nonreceptor protein tyrosine phosphatase SHP-2. This 
enzyme is involved in a wide variety of intracellular signal 
cascades and is required in several developmental processes 
[14, 25].
The main clinical features of Noonan syndrome are 
characteristic facial features, short stature, and several 
cardiac defects. Fifty to 90% of all Noonan patients have 
one or more cardiac malformations. Presented most 
frequently is pulmonary stenosis (pulmonary artery as well 
as pulmonary valve stenosis), described in 50-62% of cases 
[11, 17, 22, 24], while hypertrophic cardiomyopathy 
(HCM) occurs in 20-30% [1, 11]. Atrial and/or ventricular 
septal defects are mentioned in 5-15% of cases [11, 18, 24]. 
Some more rare malformations are coarctation of the aorta 
and structural mitral valve abnormalities [1, 12, 18]. 
Patients with a PTPN11 gene mutation more often have 
pulmonary stenosis, and patients without a PTPN11 gene 
mutation more often have hypertrophic cardiomyopathy 
[10, 26].
The electrocardiogram (ECG) of Noonan patients fre­
quently shows a characteristic pattern (Fig. 1). Typical 
features mentioned are a left axis deviation with a negative 
aVF, abnormal R/S ratio over the left precordium, and an 
abnormal Q wave [5, 7, 23]. The cause o f these 
characteristic ECG features is still unknown. In this study 
we quantify these characteristic ECG findings and evaluate 
if the ECG characteristics are an independent diagnostic 
entity, if they are related to the cardiac abnormalities found 
by echocardiography in these patients, or if they are related 
to the presence of a PTPN11 gene mutation in cases where 
gene analysis was performed.
Patients and methods
An initial cohort of 166 patients with Noonan syndrome 
from the United States (62 patients) and The Netherlands 
(104 patients) was included in this study. All patients were 
originally referred for suspected Noonan syndrome, short 
stature, or cardiac defect to the University Hospitals of 
Lexington, USA and Nijmegen, The Netherlands. The 
diagnosis of Noonan syndrome was based on previously 
published clinical criteria [16, 28] and confirmed by a 
paediatric cardiologist (JN) or clinical geneticist (IvdB). 
From the original cohort all patients who had undergone 
both an ECG and an echocardiogram were selected. 
Patients who had had surgical repair of the cardiac defects 
before the available ECG was performed were excluded. In 
this way our final study population was formed, consisting 
of 118 patients (71% of the original cohort) of which there 
were 70 males and 48 females. The median birth year of the 
patients was 1985 (range 1930-1999). The median age at 
which the ECG was performed was 6 years (range 0­
38 years). Thirty-six patients (31%)were tested for a 
PTPN11 gene mutation, and in 26 patients a PTPN11 gene 
mutation was found.
The electrocardiograms were reviewed by a paediatric 
cardiologist who had no knowledge of the presence of a 
cardiac malformation. The following characteristics were 
scored:
1. Left axis deviation: a QRS axis less than the lower limit 
of normal for the patient’s age according to Park [20].
2. An abnormal R/S ratio in V6: little R deflection over the 
left precordium with an R/S ratio lower than the lower 
limits ofnormal and R voltage in V5 and V6 less than 50% 
of the mean according to Park and Guntheroth [8, 21].
3. Abnormal Q wave: a Q voltage greater than the upper 
limit of normal and wider than 0.04 s [8].
The data were collected in SPSS and Excel. Compar­
isons between patient groups were made using Fisher exact 
test, with a significance threshold o fp <0.05.
Fig. 1 A characteristic 
electrocardiogram of a 3-month- 
old male NS patient showing 
left axis deviation and little 
R deflection over the left 
precordium
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Table 1 Statistical analysis of 
the relationship between char­
acteristic ECG abnormalities 
and cardiac defect/mutation
ECG  electrocardiogram, Fisher 
Fisher exact test
Cardiac
defect
No cardiac 
defect
Fisher
p-value
Subgroup:
mutation
Subgroup: no 
mutation
Fisher
p-value
ECG abnormalities 59 10 0.33 13 6 0.72
No ECG abnormalities 38 11 13 4
Left axis 50 9 0.63 12 5 1
No left axis 47 12 14 5
Little R 22 2 0.24 1 1 0.48
No little R 75 19 25 9
Abnormal Q 6 1 1 1 1 0.48
No Abnormal Q 91 20 25 9
Results
One or more congenital heart defects were present in 97 of 
the 118 patients with Noonan syndrome. PS was present in 
77 patients (65%), HCM in 20 patients (17%), and 12 
patients (10%) had other cardiac defects (mitral valve 
insufficiency, atrial septal defect, cleft mitral valve, aortic 
insufficiency, aortic valve malformation). Forty-five 
patients presented with more than one cardiac defect. Of 
the patients with more than one cardiac defect, 11 patients 
had PS in combination with HCM and 19 patients had PS 
in combination with atrial septal defect. There were 21 
patients (18%) without a congenital heart defect. Sixty-nine 
patients (58%) had characteristic abnormalities of the ECG. 
Fifty-nine of them (50%) had a left axis. Abnormal R/S 
ratio over the left precordium was found in 24 patients 
(20%) and 7 patients had an abnormal Q-wave on ECG. 
Sixteen patients had two characteristic ECG abnormalities 
and three patients had all three characteristic ECG 
abnormalities.
In the 21 patients without a cardiac defect, ten had a 
characteristic ECG abnormality. No statistical differences in 
the occurrence of cardiac defects were seen between 
patients with or without a characteristic ECG abnormality 
(data not shown). There was no significant statistical 
correlation between a specific ECG abnormality and the 
presence of a cardiac defect, as is shown in Table 1. We 
also evaluated the possible relationship between ECG
abnormalities and the most frequent cardiac defects, PS, 
and HCM. There was no significant statistical correlation 
between PS and one or more characteristic ECG abnormal­
ities (Table 2). For HCM there was a significant positive 
correlation with the total of ECG abnormalities, but not 
with a specific ECG abnormality (Table 2).
In the patient group that was tested for the occurrence of 
a PTPN11 mutation (36 patients), no correlation was seen 
between a characteristic ECG abnormality and the presence 
or absence of a mutation (Table 1).
Discussion
In this study it is shown that ECG abnormalities found in 
patients with Noonan syndrome are characteristic for the 
syndrome. The presence of a congenital heart defect was 
statistically independent from one of the characteristic ECG 
features. Further, almost half of the patients without a 
demonstrable congenital heart disease had the characteristic 
ECG abnormalities for Noonan syndrome. However, the 
patients with HCM had an abnormal ECG significantly 
more often. In these patients this probably reflects the 
ventricular hypertrophy. We formed an original cohort of all 
referred patients for clinical suspicion of Noonan syn­
drome, short stature, and/or suspected cardiac defects to 
prevent bias due to patients referred only for cardiac 
reasons. However, some bias could still have occurred by
Table 2 Statistical analysis of 
the relationship between char­
acteristic ECG abnormalities 
and pulmonary stenosis/hyper­
trophic cardiomyopathy
ECG  electrocardiogram, Fisher 
Fisher exact test, P S  pulmonary 
stenosis, H C M  hypertrophic 
cardiomyopathy
PS No PS Fisher HCM No HCM Fisher
ECG abnormalities 42 25 0.56 16 53 0.05
No ECG abnormalities 35 16 4 45
Left axis 34 25 0 .12 12 47 0.46
No left axis 43 16 8 51
Little R 18 6 0.34 5 19 0.55
No little R 59 35 15 79
Abnormal Q 5 2 1 1 6 1
No Abnormal Q 72 39 19 92
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selecting the patients who had undergone both an ECG and 
echocardiography. Our patient group was representative in 
the occurrence of cardiac defects as previously described 
[1, 11, 17, 22, 24], with 65% PS, 17% HCM, and 10% 
other defects in our cohort. There was no significant 
difference in occurrence of cardiac defects or characteristic 
ECG findings between the patients from The Netherlands 
and the patients from the United States (data not shown). 
With these results we assume there was no important bias in 
our patient group by referral or selection.
The patients in whom mutation analysis was performed 
did not significantly differ from the other patients with 
respect to ECG abnormalities (Table 1) or with respect to 
cardiac defects. In the genetically tested patients, no 
differences in ECG abnormalities were found, but signifi­
cant differences were found with respect to the cardiac 
defects. In the patients with a mutation, none had HCM, as 
opposed to one third in the group without a mutation. This 
is in concordance with previous observations, in which 
HCM patients less often have a PTPN11 mutation [8, 9].
A typical electrocardiogram with a left axis and an 
abnormal R/S ratio over the left precordium was first 
described in Noonan patients in 1972 [7]. The electrocar­
diography was reported earlier as being useful in the 
diagnosis of HCM [6], and Van der Burgt et al. [28] 
proposed that a typical ECG can be of value in establishing 
the diagnosis of Noonan syndrome. The present study 
strongly supports this proposal.
The exact pathophysiology of the left QRS axis is still 
unknown, but a possible explanation could be a counter­
clockwise rotation of the heart in combination with a 
conduction defect abnormality [2, 3]. There are very few 
data about the occurrence of one or more of these typical 
ECG findings in otherwise healthy children. Only the 
occurrence of a left axis deviation in healthy children has 
been studied more extensively. Calcaterra et al. [4] 
emphasize the unusual finding of a left axis deviation in 
normal children, with an incidence of 1.4%. The other 
characteristic ECG findings have not been reported in 
healthy children in the literature to our knowledge. In this 
study we showed that the above-mentioned ECG character­
istics occur in 58% of Noonan patients and that they are 
independent of the presence of a demonstrable heart 
disease. Therefore the ECG is a very useful, noninvasive 
and relatively simple diagnostic tool in the diagnosis of 
Noonan syndrome. Every child with Noonan phenotype 
should have an ECG and echocardiogram for evaluation.
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